Cantitate/Preț
Produs
Total produse
Vezi coșul
Adjuvant Therapy for Breast Cancer de Monica Castiglione

Adjuvant Therapy for Breast Cancer: Cancer Treatment and Research, cartea 151

Editat de Monica Castiglione, Martine J. Piccart
en Limba Engleză Paperback – 6 dec 2011
Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 174801 lei  6-8 săpt.
  Springer Us – 6 dec 2011 174801 lei  6-8 săpt.
Hardback (1) 139284 lei  6-8 săpt.
  Springer Us – 24 iul 2009 139284 lei  6-8 săpt.

Din seria Cancer Treatment and Research

  • 14% T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies
    Preț: 96987 lei
  • 14% HIV/AIDS-Associated Viral Oncogenesis
    Preț: 63867 lei
  • 5% Tumor Microenvironment
    Preț: 76502 lei
  • 5% Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies
    Preț: 100815 lei
  • 5% Cancer Drug Safety and Public Health Policy: A Changing Landscape
    Preț: 100301 lei
  • 5% Therapeutic Approaches in Cancer Treatment
    Preț: 101186 lei
  • 5% Targeting the DNA Damage Response for Cancer Therapy
    Preț: 89112 lei
  • 5% Threshold Decision-making in Clinical Medicine: With Practical Application to Hematology and Oncology
    Preț: 69844 lei
  • 5% Epigenetics in Oncology
    Preț: 89380 lei
  • 5% Hodgkin’s Disease in Children: Controversies and Current Practice
    Preț: 47291 lei
  • 5% Molecular Genetics and Therapy of Leukemia
    Preț: 65183 lei
  • 5% Surgical Oncology
    Preț: 49134 lei
  • 5% Adrenal and Endocrine Tumors in Children: Adrenal Cortical Carcinoma and Multiple Endocrine Neoplasia
    Preț: 70055 lei
  • 5% Lung Cancer 1
    Preț: 35984 lei
  • 15% Bayesian Methods in Reliability
    Preț: 68005 lei
  • 5% Gynecologic Oncology
    Preț: 205595 lei
  • 5% Palliative Care and Rehabilitation of Cancer Patients
    Preț: 137346 lei
  • 5% Advances in Allogeneic Hematopoietic Stem Cell Transplantation
    Preț: 138324 lei
  • 5% HIV & HTLV-I Associated Malignancies
    Preț: 107494 lei
  • 5% Thoracic Oncology
    Preț: 126035 lei
  • 5% Cancer Chemoprevention
    Preț: 107157 lei
  • 5% Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium
    Preț: 106304 lei
  • 5% Liver-Directed Therapy for Primary and Metastatic Liver Tumors
    Preț: 106499 lei
  • 5% Biology and Management of Lung Cancer
    Preț: 137295 lei
  • 5% Non-Myeloablative Allogeneic Transplantation
    Preț: 69949 lei
  • 5% Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer
    Preț: 68654 lei
  • 5% Clinically Relevant Resistance in Cancer Chemotherapy
    Preț: 71014 lei
  • 5% Biostatistical Applications in Cancer Research
    Preț: 137417 lei
  • 5% Head and Neck Cancer
    Preț: 107689 lei
  • 5% Signal Transduction in Cancer
    Preț: 106660 lei
  • 5% Kidney Cancer
    Preț: 106088 lei
  • 5% Angiogenesis in Brain Tumors
    Preț: 106801 lei
  • 5% The Biology of Skeletal Metastases
    Preț: 107459 lei

Preț: 174801 lei

Preț vechi: 184001 lei
-5% Nou

Puncte Express: 2622
Preț estimativ în valută:
33455€ • 35293$ • 27880£

Carte tipărită la comandă

Livrare economică 03-17 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461417163
ISBN-10: 1461417163
Pagini: 508
Ilustrații: XVI, 490 p. 21 illus., 6 illus. in color.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 0.7 kg
Ediția:2009
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

Basics.- History of Adjuvant Therapy.- Prognostic and Predictive Factors.- New Perspectives for Therapy Choice.- Pathology Role in Adjuvant Setting.- Guidelines, Consensus Conferences and Overviews (Meta-analysis).- Statistical Issues and Challenges.- Treatments.- Multidisciplinary Care: Optimising Team Performance.- Preoperative Chemo- and Endocrine Therapy.- Adjuvant Chemotherapy.- Postoperative Endocrine Therapy for Invasive Breast Cancer.- Adjuvant Therapy of Breast Cancer – Bisphosphonates.- New Wind in the Adjuvant Setting.- Trastuzumab.- Lapatinib: New Directions in HER2 Directed Therapy for Early Stage Breast Cancer.- Special Issues.- Supportive Care During Adjuvant Treatment.- Dose in (Adjuvant) Chemotherapy of Breast Cancer.- Timing of Adjuvant Therapy.- Sequencing of Systemic Treatment and Radiotherapy.- Special Populations.- Young Patients with Breast Cancer.- Special Populations: Elderly Patients.- Adjuvant Therapy in Patients with Breast Cancer During Pregnancy.- After Breast Cancer and Treatment, Sequelae of Adjuvant Treatment Social Issues.- Investigations After Adjuvant Therapy.- Quality of Life Issues During Adjuvant Endocrine Therapy.- Fertility.- Cognitive Function in Breast Cancer Survivors.- Costs of Adjuvant Breast Cancer Treatments.- Social Issues: Marital Support.- The View and Role of Breast Cancer Advocacy.- The Voice of a Special Patient.

Textul de pe ultima copertă

Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable.
"The adjuvant treatment of breast cancer has become standard of care. A spectrum of biologic and prognostic factors are considered before a therapeutic strategy is implemented. In this text leading investigators in the field discuss current management and critical investigative issues."
Steven T. Rosen, M.D.
Series Editor

Caracteristici

Written by leading experts in the field of breast cancer with a unique perspective, all contributors are female, except for one male breast cancer survivor Includes supplementary material: sn.pub/extras